COVID-19 Therapeutics in 2022 — Livestream

Saturday, February 26, 2022
8 a.m. – 12:10 p.m., Central time

Available credit:

  • 3.75 AMA PRA Category 1 Creditâ„¢
  • 3.75 ANCC
  • 3.75 Attendance

Mayo Clinic School of Continuous Professional Development is hosting an interactive livestream CME event on COVID-19 Therapeutics in 2022: Advances and Controversies in Evidence, Oversight, Accessibility and Utility of Therapy. This event seeks to educate and update clinicians, researchers, health care executives and policy makers on the current state of therapeutic options for COVID-19.

In this interactive livestream event, course directors DeLisa Fairweather, Ph.D., Michael J. Joyner, M.D., R. Scott Wright, M.D. and other leading experts from Mayo Clinic, Johns Hopkins and the U.S. Food and Drug Administration will address a variety of topics related to COVID-19 therapeutics, including:

  • The evolving utility of convalescent plasma in COVID-19 patients
  • Monoclonal antibody therapy for at-risk patients
  • Insights from building and managing the Mayo Clinic infusion program
  • Lessons learned from the pandemic
  • Review of the latest data regarding the safety, efficacy and future directions of vaccination for COVID-19 prevention

The event will conclude with panel questions and discussion.

Learn more and register for the course